Test Price
2,800 AED✅ Home Collection Available
BICD2 Gene Sequencing for Spinal Muscular Atrophy, Lower Extremity, Autosomal Dominant Type 2 (NGS) in UAE – 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced NGS test analyzes the BICD2 gene for pathogenic variants causing lower extremity-predominant spinal muscular atrophy type 2 with autosomal dominant inheritance, providing definitive molecular diagnosis.
| Feature | Our Test (Precision Diagnostics) | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Precision | 99.9% analytical sensitivity & specificity for BICD2 | May miss deep intronic variants; incidental findings |
| Method | Targeted NGS with full coding region ±10 bp intronic borders | Broad exome capture, less focused depth |
| Speed | 3–4 Weeks | 6–12 Weeks |
Physician Insight & Safety Protocols
“Genetic testing for BICD2 provides clarity for families affected by lower extremity spinal muscular atrophy. Interpreting the result alongside clinical and family history enables precise management and informed reproductive options. I recommend thorough pre-test counseling and post-test discussion with a genetics specialist.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory – Medication Warning
Do not discontinue prescribed medication without consulting your doctor. This genetic test is for diagnostic clarification and does not override ongoing clinical management.
Exclusion Criteria & ER Red Flags
- This test is not indicated for asymptomatic minors without explicit parental or legal guardian consent.
- Emergency red flags: If you or a family member experience acute respiratory distress, sudden limb weakness, or swallowing difficulties, seek emergency medical care immediately.
Patient FAQ & Clinical Guidance
1. What is the BICD2 gene test and why is it performed?
The BICD2 gene test detects mutations causing spinal muscular atrophy lower extremity type 2, enabling accurate diagnosis and family planning. This targeted next‑generation sequencing test evaluates the entire coding region of BICD2. A positive result confirms autosomal dominant spinal muscular atrophy‑LED2, guiding neurological surveillance and genetic counseling for at‑risk relatives.
2. How should I prepare for the BICD2 genetic test, and what does the home collection process involve?
No special preparation is needed; simply schedule a hospital‑grade home collection via WhatsApp +971 54 548 8731, and our VIP phlebotomist will arrive with a cold‑chain kit. Provide a detailed clinical history and, if possible, a pedigree chart from a prior genetic counselling session. Blood, extracted DNA, or dried blood spot on FTA card are all acceptable sample types. Samples are transported at 2–8°C to our ISO‑certified lab, ensuring chain of custody.
3. Can insurance cover the BICD2 test, and what do I do if the result is positive?
Our team verifies direct billing eligibility via WhatsApp before booking; many UAE insurers cover medically indicated genetic testing. If the result is positive, you will receive a telephonic clinical guidance session to explain the implications, followed by a referral to a neurologist and clinical geneticist. We strictly protect your genetic data under UAE PDPL and applicable health data regulations.
UAE Regulatory & Data Privacy Adherence
Your data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic results are confidential and processed under strict access controls.
Clinical & Logistical Metadata
| Test Name | BICD2 Gene Sequencing for Spinal Muscular Atrophy, Lower Extremity, Autosomal Dominant Type 2 (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Blood, Extracted DNA, or Dried Blood Spot (FTA Card) |
| Methodology Used | Targeted Next-Generation Sequencing (NGS) of BICD2 full coding region ±10 bp intronic borders |
| ICD-10-CM Code | G12.1 |
| LOINC Code | 95277-6 |
| DHA Facility License & Address | License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians